Error loading player: No playable sources found

Keynote Session I: Advantages of Emergent MS Methods for Analysis of Clinically Relevant Glycans

Date
September 14, 2020
Explore related products in the following collection:
Thumbnail for Mass Spec 2020
The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry. Mass Spectrometry is a critical analytical technology used in the discovery, development, and commercialization of biopharmaceuticals…

The heterogeneity and fragility of free glycans and the carbohydrate modifications to proteins and lipids present challenges for their analysis by mass spectrometry, but new instrumentation, accessories, and protocols can successfully address these challenges. Novel sample preparations, new ionization and scanning modes, and Electron-Based Dissociation (ExD) options offer opportunities to preserve labile modifications to biopolymers and provide both glycosidic and cross-ring cleavage information on glycans, on a time scale that is compatible with online nanoflow liquid chromatography and capillary electrophoresis, alone or in combination with ion mobility separations. Examples poised to meet expanding clinical and industry needs will include emergent methods that are already in use for medical studies, or are ready to move from our own or other research laboratories to the clinical laboratory.

Chairs

Speaker Image for Christopher Chumsae
Bristol-Myers Squibb Company
Speaker Image for Jason Rouse
Pfizer, Inc.

Speaker

Speaker Image for Catherine Costello
Boston Universtity Medical School